Sign in

CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company

IMMUNIC, INC.

Sign in to watch
Ticker
IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562358443
Phone
(332) 255-9818
Business address
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
Former names
VITAL THERAPIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 63 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-07-02 Nash Duane Director Grant or award · Stock Option +45,000 45,000
2020-07-02 HOWSON TAMAR D Director Grant or award · Stock Option +15,000 15,000
2020-07-02 PHILLIPS BARCLAY A Director Grant or award · Stock Option +15,000 15,000
2020-07-02 Neermann Joerg Director Grant or award · Stock Option +15,000 15,000
2020-07-02 van den Bossche Jan Director Grant or award · Stock Option +15,000 15,000
2020-07-02 Whaley Glenn PAO and PFO Grant or award · Stock Option +30,000 30,000
2020-07-02 Groeppel Manfred Chief Operating Officer Grant or award · Stock Option +30,000 30,000
2020-07-02 Vitt Daniel Chief Executive Officer Grant or award · Stock Option +80,000 80,000
2020-04-29 Whaley Glenn PAO and PFO Grant or award · Stock Option +15,000 15,000
2019-12-04 Nash Duane Director Sale −4,400 $6.96 $31K 10,032
2019-12-03 Nash Duane Director Shares withheld for taxes −7,930 $7.15 $57K 14,432
2019-12-02 Nash Duane Director Option exercise +22,157 22,362
2019-12-02 Nash Duane Director Option exercise · Restricted Stock Units −22,157 864,159
2019-12-01 Whaley Glenn PAO and Controller Grant or award · Stock Option +15,000 15,000
2019-11-18 PHILLIPS BARCLAY A Director Grant or award · Stock Option +29,959 29,959
2019-10-11 HOWSON TAMAR D Director Grant or award · Stock Option +29,959 29,959
2019-08-01 Groeppel Manfred Chief Operating Officer Grant or award · Stock Option +20,000 20,000
2019-08-01 Vitt Daniel Chief Executive Officer Grant or award · Stock Option +65,000 65,000
2019-07-22 van den Bossche Jan Director Grant or award · Stock Option +29,959 29,959
2019-07-22 Patel Sanjay S Chief Financial Officer Grant or award · Stock Option +79,891 79,891

Page 11 of 16 · 311 trades